Theragen Etex Co.,Ltd. (KOSDAQ:066700)
South Korea · Delayed Price · Currency is KRW 2,840.00
-40.00 (-1.39%)
At close: Feb 13, 2026
Theragen Etex Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | -46,449 | -40,985 | 26,211 | 9,561 | -11,854 | -8,968 |
Depreciation & Amortization | 6,456 | 6,096 | 5,844 | 5,092 | 5,041 | 4,655 |
Loss (Gain) From Sale of Assets | -1,298 | -5,845 | -22,445 | -4,231 | 219.2 | 66.21 |
Asset Writedown & Restructuring Costs | 26.22 | 26.22 | 62.69 | 800.7 | 1,477 | 297.74 |
Loss (Gain) From Sale of Investments | -7.65 | -17.38 | -29.65 | -4.22 | - | 16.91 |
Loss (Gain) on Equity Investments | 53,415 | 54,747 | 357.07 | 65.07 | -12.93 | 27.73 |
Stock-Based Compensation | 581.57 | 161.9 | 659.55 | - | -0.75 | 154.38 |
Provision & Write-off of Bad Debts | 718.92 | 184.24 | 1,776 | -1,465 | 7,441 | 1,275 |
Other Operating Activities | -1,179 | -999.05 | 4,685 | 3,480 | 377.47 | 1,995 |
Change in Accounts Receivable | -5,481 | -1,181 | -8,712 | -3,202 | -7,168 | 9,282 |
Change in Inventory | -1,798 | -13,208 | -1,815 | -4,256 | 2,021 | 1,711 |
Change in Accounts Payable | -491.27 | 2,354 | 2,448 | 3,773 | 1,443 | -1,374 |
Change in Other Net Operating Assets | 1,524 | 454.79 | 3,083 | -19.87 | 5,022 | 4,089 |
Operating Cash Flow | 6,017 | 1,788 | 12,125 | 9,593 | 4,007 | 13,227 |
Operating Cash Flow Growth | -36.67% | -85.25% | 26.39% | 139.43% | -69.71% | 34997.10% |
Capital Expenditures | -4,253 | -11,392 | -4,797 | -4,193 | -2,749 | -3,012 |
Sale of Property, Plant & Equipment | 623.12 | 727.26 | 9 | - | 24.64 | 44.1 |
Cash Acquisitions | 0 | -1,091 | -195.58 | - | - | - |
Divestitures | 5,614 | 6,980 | 30 | - | - | - |
Sale (Purchase) of Intangibles | -1,503 | -2,805 | -818.91 | -2,337 | -1,090 | -1,975 |
Investment in Securities | -6,055 | -6,303 | -9,526 | -2,166 | -129.51 | -193.88 |
Other Investing Activities | 620.5 | -105.76 | 185.47 | 8,804 | 257.42 | -89.08 |
Investing Cash Flow | 675.77 | -14,016 | -13,779 | 1,875 | -2,924 | -7,621 |
Long-Term Debt Issued | - | 40,696 | 37,471 | 1,000 | 5,367 | 29,621 |
Total Debt Issued | 5,185 | 40,696 | 37,471 | 1,000 | 5,367 | 29,621 |
Long-Term Debt Repaid | - | -28,038 | -32,379 | -7,612 | -8,857 | -31,850 |
Total Debt Repaid | -19,593 | -28,038 | -32,379 | -7,612 | -8,857 | -31,850 |
Net Debt Issued (Repaid) | -14,408 | 12,658 | 5,091 | -6,612 | -3,490 | -2,230 |
Issuance of Common Stock | 12,997 | - | - | - | 387.79 | 1,091 |
Dividends Paid | -99.14 | -99.14 | - | - | - | - |
Other Financing Activities | -0 | -0 | - | 1,336 | - | 0 |
Financing Cash Flow | -1,510 | 12,559 | 5,091 | -5,276 | -3,103 | -1,139 |
Foreign Exchange Rate Adjustments | 339.22 | 142.24 | -25.59 | -76.94 | -89.74 | -48.26 |
Miscellaneous Cash Flow Adjustments | 0 | - | - | - | -0 | 0 |
Net Cash Flow | 5,522 | 473.15 | 3,412 | 6,116 | -2,109 | 4,419 |
Free Cash Flow | 1,764 | -9,604 | 7,328 | 5,401 | 1,257 | 10,214 |
Free Cash Flow Growth | - | - | 35.69% | 329.54% | -87.69% | - |
Free Cash Flow Margin | 0.66% | -3.85% | 3.38% | 2.83% | 0.76% | 7.14% |
Free Cash Flow Per Share | 47.28 | -300.06 | 228.96 | 168.74 | 39.30 | 325.27 |
Cash Interest Paid | 2,420 | 2,326 | 1,604 | 1,222 | 1,009 | 956.47 |
Cash Income Tax Paid | 4,982 | 4,428 | 2,216 | 1,599 | 794.65 | 1,150 |
Levered Free Cash Flow | -73.59 | -12,795 | 3,651 | 2,886 | 6,272 | 11,489 |
Unlevered Free Cash Flow | 1,517 | -11,122 | 5,162 | 3,725 | 7,329 | 12,829 |
Change in Working Capital | -6,247 | -11,581 | -4,996 | -3,705 | 1,318 | 13,707 |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.